SureTrader
Interactive Brokers Advertisement
Home > Boards > US OTC > Medical - Drugs >

Synergy Pharmaceuticals Inc (SGYP)

SGYP RSS Feed
Add SGYP Price Alert      Hide Sticky   Hide Intro
Moderator: Snackman
Search This Board: 
Last Post: 10/19/2017 4:17:42 PM - Followers: 136 - Board type: Free - Posts Today: 0

http://www.synergypharma.com/Welcome.html

http://www.callistopharma.com.

Synergy Pharmaceuticals, Inc., a development stage biopharmaceutical company, engages in the development of drugs to treat gastrointestinal disorders and diseases in the United States. Its lead product candidate is Plecanatide, a guanylyl cyclase C (GC-C), receptor agonist, which is in Phase II/III clinical trials to treat gastrointestinal disorders, primarily chronic constipation. The company also develops Plecanatide for the treatment of constipation-predominant-irritable bowel syndrome. In addition, it develops SP-333, a second generation GC-C receptor analog that is in pre-clinical development stage for the treatment of gastrointestinal inflammatory diseases, such as ulcerative colitis and Crohn's disease. The company is headquartered in New York, New York.



SureTrader
Interactive Brokers Advertisement
SGYP
Current Price
Volume:
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
SGYP News: Synergy Pharmaceuticals Presents Results from Study Examining Patient & Physician Perceptions & Experiences with Irritable Bo... 10/17/2017 10:30:00 AM
SGYP News: Synergy Pharmaceuticals to Highlight New Data for TRULANCE® (Plecanatide) at the World Congress of Gastroenterology (WCOG) a... 10/12/2017 09:30:00 AM
SGYP News: CORRECTING and REPLACING Synergy Pharmaceuticals to Present at Upcoming September Investor Conferences 09/21/2017 07:54:00 PM
SGYP News: Current Report Filing (8-k) 09/06/2017 08:42:18 AM
SGYP News: Synergy Pharmaceuticals to Present at Upcoming September Investor Conferences 09/06/2017 08:30:00 AM
PostSubject
#2927   Ram was pounding the table when it was biotech_researcher 10/19/17 04:17:41 PM
#2926   H.C. Wainwright Pounds the Table on Synergy Pharmaceuticals Snackman 10/19/17 01:42:36 AM
#2924   My experience having invested in Amarin when they fsulevine 10/18/17 03:46:33 PM
#2923   I don't think there is going to be buddwhyzer 10/18/17 11:39:31 AM
#2922   Added some more with the slight dip this fsulevine 10/18/17 10:02:43 AM
#2921   They announced results from a questionnaire? Wow. All buddwhyzer 10/17/17 02:45:17 PM
#2920   Synergy Pharmaceuticals Presents Results from Study Examining Patient Snackman 10/17/17 01:39:39 PM
#2919   Synergy Pharmaceuticals to Highlight New Data for TRULANCE® Snackman 10/14/17 12:03:42 PM
#2918   As expected, the weekly prescription numbers are going Infominer777 10/13/17 08:57:49 AM
#2917   It’s a problem for Ardelyx….their drug has three-times Snackman 10/12/17 04:06:30 PM
#2916   ARDX - The company is touting best-in-class responder iandy 10/12/17 02:34:14 PM
#2915   Synergy Pharma (SGYP) - the biotech pulls back Snackman 10/12/17 11:53:00 AM
#2914   Synergy Pharmaceuticals to Highlight New Data for TRULANCE® Snackman 10/12/17 11:29:29 AM
#2906   To see the charts in this article go Snackman 10/09/17 09:51:50 PM
#2905   I want my money back, I joined the BostonSportsNut 10/09/17 08:22:56 PM
#2904   You should have a double by then without iandy 10/09/17 09:49:46 AM
#2903   Nice article. I'm in at 2.95 and scottsmith 10/07/17 10:23:13 AM
#2902   Synergy has suffered due to slower than anticipated Snackman 10/07/17 09:58:41 AM
#2901   * * $SGYP Video Chart 10-05-17 * * ClayTrader 10/05/17 04:34:42 PM
#2900   The market for IBS-C is roughly 1/3 the iandy 10/05/17 10:38:39 AM
#2899   Well, average weekly growth overall is 10.8%, for Fatass 10/05/17 09:14:45 AM
#2898   Are we currently at 1% weekly growth? iandy 10/05/17 08:58:36 AM
#2897   Sorry that's 2018 and 2019 of course Fatass 10/05/17 07:38:35 AM
#2896   Trulance is covered by 45% of insurance plans BigWorm129 10/05/17 06:46:18 AM
#2895   Who will take it out? 2to10by40 10/05/17 05:36:34 AM
#2894   I noticed one of the more recent reports Fatass 10/05/17 04:31:12 AM
#2893   Hey ClayTrader, thanks for the videos, good stuff. Fatass 10/05/17 04:14:53 AM
#2892   * * $SGYP Video Chart 10-04-17 * * ClayTrader 10/04/17 04:51:53 PM
#2891   Impressive. Thanks, Opti Opti Mist 10/04/17 09:51:47 AM
#2890   Here is part of the article: Snackman 10/04/17 08:36:03 AM
#2889   https://seekingalpha.com/article/4111440-synergy-pharmaceuticals-first-commercia eyeofstorm 10/04/17 06:17:05 AM
#2888   * * $SGYP Video Chart 10-03-17 * * ClayTrader 10/03/17 04:57:28 PM
#2886   You nailed that one! MDizzle 10/03/17 09:47:24 AM
#2885   * * $SGYP Video Chart 10-02-17 * * ClayTrader 10/02/17 04:27:40 PM
#2884   Gltu _55 10/02/17 03:40:02 PM
#2883   Don't be so sad. I already covered 3.18 _55 10/02/17 03:39:47 PM
#2882   I think it’s just a penny stock stray. iandy 10/02/17 02:42:56 PM
#2881   Run? It’s only up 20% on the recent Xander3 10/02/17 02:32:46 PM
#2880   Wonder how many, if any shorts are....smart enough BostonSportsNut 10/02/17 01:09:17 PM
#2879   Trash stock. Run is over _55 10/02/17 11:48:06 AM
#2878   1. the valuatîon is clearly on the low side 2to10by40 10/02/17 08:58:40 AM
#2877   I am noticing all the ads for Lizeness Snackman 10/02/17 01:58:45 AM
#2876   I agree with Scott Smith. Infominer777 10/01/17 09:57:29 PM
#2875   I read that blurp, and I think attributing scottsmith 09/30/17 09:23:03 AM
#2874   Why Synergy Pharmaceuticals Rallied 12% Today Snackman 09/30/17 02:35:03 AM
#2873   Reverse reason it declined every other day. Opti Mist 09/29/17 05:31:52 PM
#2872   * * $SGYP Video Chart 09-29-17 * * ClayTrader 09/29/17 05:05:36 PM
#2871   Anyone know why it ran today? zerowinner 09/29/17 03:54:51 PM
#2870   Hopefully this is good news. I got in tste9 09/29/17 11:04:32 AM
#2869   Expect $5.00 before the year is out. scottsmith 09/29/17 06:50:24 AM
PostSubject